Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 4366 AL 4380

Regulatory mechanisms and therapeutic potential of natural microglia inhibitors in Parkinson's disease

Jin TT, Shi RZ, Shi JW, Liu F, Liang YX.

J Asian Nat Prod Res. 2025 Aug 28:1-22. doi: 10.1080/10286020.2025.2544148. Online ahead of print.

Mitochondria: Key Mediator for Environmental Toxicant-Induced Neurodegeneration

Shah N, Saxena B, Gupta R.

Int J Toxicol. 2025 Nov-Dec;44(6):507-525. doi: 10.1177/10915818251369414. Epub 2025 Aug 28.

Correction: Green, innovative oral capsules of three anti-Parkinson's drugs: formulation, in vitro evaluation, and robust RP-HPLC validation

Mahgoub SM, Alawam AS, Rudayni HA, Allam AA, Ezzat KH, Elsuccary SAA, Radalla AM, Mahmoud R.

Anal Methods. 2025 Sep 11;17(35):7126. doi: 10.1039/d5ay90112j.

Clinical Impact of Switching from Subcutaneous Apomorphine to Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: A Real-World Observational Study (FOSAPO)

Desjardins C, Salardaine Q, Brandel JP, Baille G.

Mov Disord Clin Pract. 2025 Dec;12(12):2330-2336. doi: 10.1002/mdc3.70254. Epub 2025 Jul 24.

Analysis of DBS Outcome by MDS-UPDRS Severity Levels: Comparison with Changes on MDS-UPDRS III

Castillo-Torres SA, Cruz I, Rossi M, Wilken M, Cerquetti D, Merello M.

Mov Disord Clin Pract. 2025 Dec;12(12):2324-2329. doi: 10.1002/mdc3.70244. Epub 2025 Jul 22.

The effect of diet on Parkinson's disease progression, symptoms and severity: a review of randomised controlled trials

Prasad A, Glover C, Shuler MS, Dayal V, Lithander FE.

Proc Nutr Soc. 2025 Aug 29:1-15. doi: 10.1017/S0029665125101213. Online ahead of print.

Comparison of Two α-Synuclein Seed Amplification Assays for Discrimination of Parkinson Disease and Atypical Parkinsonism

Rossi M, Farris CM, Baiardi S, Giannini G, Magliocchetti F, Sambati L, Ma Y, Vittoriosi E, Calandra-Buonaura G, Concha-Marambio L, Parchi P.

Mov Disord. 2025 Nov;40(11):2504-2509. doi: 10.1002/mds.70017. Epub 2025 Aug 20.

Recessive Loss of PI4K2A Function Causes a Developmental and Epileptic Dyskinetic Encephalopathy with Prominent Orolingual Dyskinesia

Maroofian R, Ortigoza-Escobar JD, Rohilla P, Alvi JR, Mushiba AM, Almontashiri NAM, Efthymiou S, Sultan T, Balla T, Houlden H.

Mov Disord. 2025 Oct;40(10):2243-2250. doi: 10.1002/mds.30286. Epub 2025 Aug 7.

Biomarkers and neuroimaging markers in Parkinson's disease

Su D, Zheng Y, Feng T.

Chin Med J (Engl). 2025 Oct 5;138(19):2365-2380. doi: 10.1097/CM9.0000000000003745. Epub 2025 Aug 18.

Targeting glucose transporters in parkinson's disease: a novel metabolic approach for disease modification

Singh G, Ansari S, Aran KR.

Metab Brain Dis. 2025 Aug 29;40(7):253. doi: 10.1007/s11011-025-01697-5.

Exploring novel roles of lipid droplets and lipid metabolism in regulating inflammation and blood-brain barrier function in neurological diseases

Fu L, Luo T, Hao Z, Pan Y, Xin W, Zhang L, Lai Z, Zhang H, Liu H, Wei W.

Front Neurosci. 2025 Aug 13;19:1603292. doi: 10.3389/fnins.2025.1603292. eCollection 2025.

Biological and translational attributes of mitochondrial DNA copy number: Laboratory perspective to clinical relevance

Parchwani D, Singh R, Patel D.

World J Methodol. 2025 Sep 20;15(3):102709. doi: 10.5662/wjm.v15.i3.102709. eCollection 2025 Sep 20.

Editorial: Magnetic Resonance-guided Focused Ultrasound (MRgFUS)

Pistoia F, Gallay M, Tinazzi M.

Front Neurol. 2025 Aug 12;16:1658187. doi: 10.3389/fneur.2025.1658187. eCollection 2025.

Precision intervention of virtual reality training for balance and gait in Parkinson's disease: a dose-response meta-analysis

Wu H, Zhang C.

Front Neurol. 2025 Aug 13;16:1616780. doi: 10.3389/fneur.2025.1616780. eCollection 2025.

Editors' Note: Migraine and Risk of Parkinson Disease in Women: A Cohort Study

Ganesh A, Galetta SL.

Neurology. 2025 Sep 23;105(6):e214084. doi: 10.1212/WNL.0000000000214084. Epub 2025 Aug 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias